EHRA 22: Early Rhythm Control Therapy For AF Patients Found To Reduce Cardiovascular Outcomes

Подробнее о видео

Watch on Radcliffe Cardiology:

In this short late-breaking interview, Dr Jason Andrade (Vancouver General / Montreal Heart Institute, Montreal, CA) joins us at EHRA 2022 to outline the findings of a meta-analysis of EAST-AFNET 4. The main outcomes suggest that early rhythm control therapy is beneficial for AF patients, reducing their cardiovascular outcomes.

Discussion points:
- Reasoning behind this meta-analysis
- Study design and patient population
- Key findings
- Take-home messages
- Further research required

Recorded on-site in Copenhagen, EHRA Conference 2022.
Interviewer: Jonathan McKenna
Editor: Jordan Rance

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.